首页|度拉糖肽联合甘精胰岛素治疗2型糖尿病患者的疗效观察

度拉糖肽联合甘精胰岛素治疗2型糖尿病患者的疗效观察

扫码查看
目的 探讨度拉糖肽联合甘精胰岛素对2型糖尿病患者糖脂代谢、胰岛功能、氧化应激、骨代谢指标的影响.方法 将98例2型糖尿病患者随机分为甘精胰岛素组和联合组,每组49例.甘精胰岛素组使用甘精胰岛素联合二甲双胍治疗,联合组使用度拉糖肽、甘精胰岛素联合二甲双胍治疗.比较2组患者治疗前后血糖、血脂、胰岛功能指标水平;采用酶标分析仪检测氧化应激指标水平;采用免疫透射比浊法检测骨代谢指标;计算2组尿微量白蛋白与尿肌酐比值(UACR),比较2组治疗效果.结果 治疗后,联合组空腹血糖(FPG)、餐后2 h血糖(2 hPG)、糖化血红蛋白(HbAlc)水平均低于甘精胰岛素组,差异有统计学意义(P<0.05).治疗后,联合组总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)水平低于甘精胰岛素组,高密度脂蛋白(HDL)水平高于甘精胰岛素组,差异有统计学意义(P<0.05).治疗后,联合组胰岛β细胞功能指数(HOMA-IS)高于甘精胰岛素组,胰岛素抵抗指数(HOMA-IR)低于甘精胰岛素组,差异有统计学意义(P<0.05).治疗后,联合组过氧化氢酶(CAT)、骨钙素(OC)水平高于甘精胰岛素组,过氧化脂质(LPO)、β-胶原降解产物(β-CTX)水平低于甘精胰岛素组,差异有统计学意义(P<0.05).治疗后,联合组UACR水平为(33.26±3.37)mg/g,高于甘精胰岛素组的(25.49±2.83)mg/g,差异有统计学意义(P<0.05).联合组治疗总有效率为93.88%,高于甘精胰岛素组的79.59%,差异有统计学意义(P<0.05).结论 度拉糖肽联合甘精胰岛素能够有效调节2型糖尿病患者血糖及血脂水平,改善患者胰岛功能,减轻氧化应激反应,改善骨代谢,调节UACR水平.
Efficacy observation of dulaglutide combined with insulin glargine in treating patients with type 2 diabetes mellitus
Objective To investigate the effects of dulaglutide combined with insulin glargine on glucose and lipid metabolism,pancreatic islet function,oxidative stress and bone metabolism indica-tors in patients with type 2 diabetes mellitus.Methods A total of 98 patients with type 2 diabetes mellitus were randomly divided into insulin glargine group and combined group,with 49 cases in each group.The insulin glargine group was treated with insulin glargine and metformin,while the com-bined group was treated with dulaglutide,insulin glargine and metformin.The levels of blood glu-cose,blood lipids and pancreatic islet function were compared between the two groups before and after treatment;enzyme immunoassay analyzer was used to detect the levels of oxidative stress indicators;immunoturbidimetry was used to detect bone metabolism indicators;the urinary microalbumin to creat-inine ratio(UACR)was calculated in both groups,and the therapeutic effect was compared between the two groups.Results After treatment,the levels of fasting plasma glucose(FPG),2-hour post-prandial glucose(2 hPG)and glycated hemoglobin(HbA1c)in the combined group were significantly lower than those in the insulin glargine group(P<0.05).After treatment,the levels of total cholesterol(TC),triglycerides(TG)and low-density lipoprotein cholesterol(LDL-C)in the combined group were significantly lower than those in the insulin glargine group,while the level of high-density lipo-protein(HDL)was significantly higher than that in the insulin glargine group(P<0.05).After treatment,the homeostatic model assessment of insulin secretion(HOMA-IS)in the combined group was significantly higher than that in the insulin glargine group,while the homeostatic model assess-ment of insulin resistance(HOMA-IR)was significantly lower than that in the insulin glargine group(P<0.05).After treatment,the levels of catalase(CAT)and osteocalcin(OC)in the combined group were significantly higher than those in the insulin glargine group,while the levels of lipid per-oxide(LPO)and β-collagen degradation products(β-CTX)were significantly lower than those in the insulin glargine group(P<0.05).After treatment,the UACR in the combined group was(33.26±3.37)mg/g,which was significantly higher than(25.49±2.83)mg/g in the insulin glargine group(P<0.05).The total effective rate in the combined group was 93.88%,which was significantly higher than 79.59%in the insulin glargine group(P<0.05).Conclusion Dulaglu-tide combined with insulin glargine can effectively regulate the blood glucose and lipid levels of pa-tients with type 2 diabetes,improve the function of pancreatic islets,alleviate the oxidative stress re-action,improve bone metabolism,and regulate the UACR level.

type 2 diabetesdulaglutideinsulin glargineglycolipid metabolisminsulin resistance indexβ-collagen degradation productsurinary microalbumin-to-creatinine ratio

缪佳、张柳柳、刘孟雪

展开 >

皖南医学院第二附属医院药剂科,安徽芜湖,241000

2型糖尿病 度拉糖肽 甘精胰岛素 糖脂代谢 胰岛素抵抗指数 β-胶原降解产物 尿微量白蛋白与尿肌酐比值

皖南医学院第二附属医院"恒瑞·天晴医学教育基金"横向课题

HXKT2022026

2024

实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
年,卷(期):2024.28(7)
  • 21